Showing results (81-90 of 187) with videos related to
Sort By:
Pageof 19
Journal of Cancer Research and Clinical Oncology|January 23, 2023
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignanciesSven H Loosen, Markus S Jördens, Berenike Schoon, et al.Plos One|January 23, 2024
Surgical and per-oral endoscopic myotomy (POEM) for the treatment of primary esophageal motility disorders: A systematic analysis of current trends in Germany between 2011 and 2019Jennis Kandler, Tobias Essing, David Schöler, et al.Canadian Journal of Gastroenterology & Hepatology|November 1, 2024
Acute Variceal Hemorrhage in Germany-A Nationwide Study of 65,357 Hospitalized Cases: Variceal Hemorrhage in GermanyAlexander Mertens, Tobias Essing, Anselm Kunstein, et al.BMJ Open Diabetes Research & Care|May 29, 2021
Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetesSven H Loosen, Münevver Demir, Anselm Kunstein, et al.Scientific Reports|February 18, 2022
The spectrum of comorbidities at the initial diagnosis of heart failure a case control studySven H Loosen, Christoph Roderburg, Ole Curth, et al.Journal of Clinical Medicine|December 24, 2021
Incidence of Cancer in Patients with Irritable Bowl SyndromeSven H Loosen, Markus S Jördens, Mark Luedde, et al.Biomedicines|February 25, 2023
The Association between Antibiotic Use and the Incidence of Heart Failure: A Retrospective Case-Control Study of 162,188 OutpatientsSven H Loosen, Sarah Krieg, Julia Gaensbacher, et al.Journal of Clinical Medicine|November 26, 2022
Antihypertensive Therapy and Incidence of CancerSven H Loosen, David Schöler, Mark Luedde, et al.Zeitschrift Fur Gastroenterologie|November 25, 2021
Current epidemiological trends and in-hospital mortality of acute pancreatitis in Germany: a systematic analysis of standardized hospital discharge data between 2008 and 2017Sven H Loosen, Tobias Essing, Markus Jördens, et al.Alimentary Pharmacology & Therapeutics|March 8, 2023
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohortFabian Jost-Brinkmann, Münevver Demir, Alexander Wree, et al.Pageof 19